Abstract
Vitiligo is an acquired disease of loss of skin pigment, probably due to autoimmune destruction of melanocytes. Hypopigmentation is the clinical sign of a lighter-coloured macule or patch compared with the background skin colour, regardless of cause. Depigmentation is loss of skin pigmentation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Maatouk I. Vitiligo-like lesions following imiquimod 5% application for condyloma acuminata: an additional case. Indian J Dermatol Venereol Leprol. 2016;82:572–4.
Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149:159–64.
Morales-Sánchez MA, Vargas-Salinas M, Peralta-Pedrero ML, OlguÃn-GarcÃa MG, Jurado-Santa Cruz F. Impact of vitiligo on quality of life. Actas Dermosifiliogr. 2017;108:637–42.
Li X, Hong W, Xu AE. Two cases of focal scrotal vitiligo successfully treated by autologous cultured melanocyte transplantation. Dermatol Ther (Heidelb). 2014;4:141–4.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hall, A. (2019). Vitiligo and Acquired Depigmentation. In: Atlas of Male Genital Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-99750-6_48
Download citation
DOI: https://doi.org/10.1007/978-3-319-99750-6_48
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99749-0
Online ISBN: 978-3-319-99750-6
eBook Packages: MedicineMedicine (R0)